Edition:
United Kingdom

Astrazeneca Pharma India gets marketing approval for combination of therapies for type 2 diabetes‍​


Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Astrazeneca Pharma India Ltd ::Gets marketing approval for Xigduo XR, combination of two anti-diabetic therapies for type 2 diabetes‍​. 

Company Quote

1945.4
57.55 +3.05%
10:59am BST